← Back to all trials
Completed
NCT05609955
Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac
Conditions: Anesthesia, Pain, Postoperative, Surgery, Opioid Use
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: 1
Phase: PHASE4
Enrollment: 48
Sponsor: Indonesia University
Location: Indonesia
Summary
This study aims to compare two groups of post-orthopedic patients who received a standard regimen, namely ketorolac 30mg, to the second group, which was given the standard regimen and adjuvant magnesium sulfate 30mg/kgBW 1 hour preoperatively.
If it is proven useful, it is hoped that pain will be more controlled, reduce pain complications, reduce treatment costs, and reduce the duration of hospital stays.
Eligibility Criteria
Inclusion Criteria:Patients undergoing lower extremity orthopedic surgery under general anaesthesia.Patients aged 18-60 years.Physical status ASA 1-3Willing to participate in research.Exclusion Criteria:Patients who are hemodynamically unstable.Patients with decreased renal functionPatients with skeletal muscle disorders.Patients with Ketorolac allergyPatients with morphine allergy
Source: ClinicalTrials.gov (NCT05609955). StuddyBuddy aggregates publicly available trial information.
